FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a new two-layer pharmaceutical dosage form of tablets for use in the treatment of HIV. A tablet contains dolutegravir, the HIV integrase strand transfer inhibitor together with lamivudine, nucleoside reverse transcriptase inhibitor.
EFFECT: obtaining two-layer pharmaceutical dosage form of tablets.
6 cl, 2 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR | 2010 |
|
RU2602865C2 |
| COMBINATION, ITS APPLICATION AND METHODS FOR TREATMENT USING SPECIFIED COMBINATION | 2018 |
|
RU2755710C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIRETROVIRAL DRUG AND PHARMACOKINETICS IMPROVER | 2017 |
|
RU2745204C2 |
| CENICRIVIROC COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2014 |
|
RU2633069C2 |
| PHARMACEUTICAL ANTIRETROVIRAL COMPOSITION | 2013 |
|
RU2648457C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
| MEDICINE DELIVERY REGULATED SYSTEM CONTAINED IN STOMACH | 2002 |
|
RU2325152C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN | 2007 |
|
RU2401107C2 |
| METHOD OF TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE | 2020 |
|
RU2840867C1 |
| TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES | 2004 |
|
RU2380093C2 |
